Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of post-ERCP pancreatitis with rectal naproxen, isosorbide dinitrate, or both
IRCT201409251155N22Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of naproxen and isosorbide dinitrate in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) (3 arms), sponsored by Guilan University of Medical Sciences. Started Jun 2015; status: completed.
02
Drugs
naproxenisosorbide dinitrate
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on IRCT201409251155N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201409251155N22.